TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 88 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $309,000 | – | 864,322 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 734,477 | $441,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 516,218 | $310,000 | 0.03% |
Game Plan Financial Advisors, LLC | 27,216 | $16,000 | 0.01% |
MONECO Advisors, LLC | 35,000 | $21,000 | 0.01% |
Purus Wealth Management, LLC | 15,000 | $9,000 | 0.01% |
Renaissance Technologies | 6,038,664 | $3,630,000 | 0.01% |
Qube Research & Technologies Ltd | 540,878 | $325,000 | 0.00% |
D. E. Shaw & Co., Inc. | 6,690,867 | $4,022,000 | 0.00% |
Cutter & CO Brokerage, Inc. | 19,000 | $11,000 | 0.00% |
WINTON GROUP Ltd | 61,977 | $37,000 | 0.00% |